Arthritis Research & Therapy

official impact factor 4.36

This article is part of the supplement: Current perspectives on the treatment of rheumatic diseases with infliximab

Autoantibodies in rheumatoid arthritis and their clinical significance

Günter Steiner* and Josef Smolen

Arthritis Res 2002, 4(Suppl 2):S1-S5 doi:10.1186/ar551

Accesses  

  • Last 30 days: 142 accesses
  • Last 365 days: 1335 accesses
  • All time: 11218 accesses

Cited by

BioMed Central: 4 citations

Research article   Open Access

Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis

Ioannis Alexiou, Anastasios Germenis, Athanasios Ziogas, Katerina Theodoridou, Lazaros I Sakkas BMC Musculoskeletal Disorders 2007, 8:37 (20 April 2007)

Review   Free

The role of the complement and the FcγR system in the pathogenesis of arthritis

Samuel Solomon, Daniela Kassahn, Harald Illges Arthritis Research & Therapy 2005, 7:129-135 (16 May 2005)

Research article   Open Access Highly Accessed

Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity

Karin Lundberg, Suzanne Nijenhuis, Erik R Vossenaar, Karin Palmblad, Walter J van Venrooij, Lars Klareskog, AJW Zendman, Helena Harris Arthritis Research & Therapy 2005, 7:R458-R467 (21 February 2005)

Viewpoint   Free

Direct interaction of immunoglobulins with synovial fibroblasts: a missing link in the pathogenesis of rheumatoid arthritis?

Thomas Pap Arthritis Res Ther 2005, 7:44-46 (20 December 2004)